Nanogen releases new real-time PCR reagents

July 17, 2006 – Nanogen Inc., a San Diego developer of diagnostic products, announced that it has expanded its product portfolio to include MGB Alert real-time PCR reagents designed to assist laboratories in developing tests that can detect sequences associated with varicella-zoster virus (VZV, also called Human Herpesvirus 3) and Bordetella bacteria.

Vaccines exist for both VZV and Bordetella, but the conditions they cause remain endemic for several reasons. The company says all its MGB Alert products use detection chemistry that enables laboratories to develop multiple assays with universal parameters, increasing the efficiency and throughput of clinical testing.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.